GLP-1 & Metabolic Psychiatry at AAAP 37th Annual Meeting and Scientific Symposium

Thursday, November 12

• 09:00–10:40 · Symposium

  Symposium I - From Metabolism to Addictions: Repurposing GLP-1 Therapies for Alcohol and Other Substance Use Disorders

  Lorenzo Leggio · Joji Suzuki · Luba Yammine · Manish Jha

  Reviews preclinical, observational and early randomized trial evidence on using GLP-1 receptor agonists to treat alcohol and other substance use disorders, including psychiatric safety.

  Alcohol Use Disorder · Substance Use Disorders

Sunday, November 15

Posters (3)

• Beyond Weight Loss: GLP- 1 Receptor Agonists for Alcohol Use Disorder- A Systematic Review and Meta-Analysis — Ramita Goel
• Expanding the Therapeutic Landscape of Alcohol Use Disorder: Brenipatide (Dual GIP/GLP-1 Receptor Agonist) Clinical Trials — Marc Fishman
• GLP-1 Receptor Agonists in Alcohol Use Disorder: Outcome-Domain Synthesis With Exploratory Aggregate-Data Pooling of Randomized Trials — Mahnoor Waqar

Schedule to be announced

• Symposium · Symposia

  From Metabolism to Addictions: Repurposing GLP-1 Therapies for Alcohol and Other Substance Use Disorders

  Lorenzo Leggio · Joji Suzuki · Luba Yammine · Manish Jha

  Surveys preclinical and emerging clinical evidence for GLP-1 receptor agonists as candidate treatments for alcohol and other substance use disorders.

  Alcohol Use Disorder · Substance Use Disorders